Role of ceramide synthase 2 in G-CSF signaling and G-CSF-R translocation into detergent-resistant membranes.
Animals
Bone Marrow Cells
/ drug effects
Cell Membrane
/ drug effects
Cell Movement
/ drug effects
Detergents
/ pharmacology
Disease Models, Animal
Encephalomyelitis, Autoimmune, Experimental
/ genetics
Gene Expression Regulation
/ drug effects
Granulocyte Colony-Stimulating Factor
/ genetics
Humans
Lactosylceramides
/ metabolism
Mice
Multiple Sclerosis
/ genetics
Neutrophils
/ drug effects
Protein Transport
/ drug effects
Receptors, Granulocyte Colony-Stimulating Factor
/ genetics
STAT3 Transcription Factor
/ genetics
Sphingosine N-Acyltransferase
/ genetics
src-Family Kinases
/ genetics
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
24 01 2019
24 01 2019
Historique:
received:
24
07
2018
accepted:
06
12
2018
entrez:
26
1
2019
pubmed:
27
1
2019
medline:
25
7
2020
Statut:
epublish
Résumé
Ceramides are sphingolipids with defined acyl chain lengths, which are produced by corresponding ceramide synthases (CerS1-6). In experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS), the ablation of CerS2 suppresses EAE-pathology by reducing neutrophil migration into the central nervous system. This migration is induced by granulocyte-colony stimulating factor (G-CSF) signaling. G-CSF signaling leads to a signal cascade including the phosphorylation of Lyn kinase and STAT3. This in turn regulates expression of the neutrophil surface receptor chemokine receptor 2 (CXCR2) and causes translocation of the receptor into detergent-resistant membranes (DRMs). In this study we investigated the role of ceramides in G-CSF signaling. We found, that G-CSF treatment of wild type bone marrow cells (BMCs) leads to translocation of G-CSF-receptor (G-CSF-R) into DRMs. G-CSF also induces downregulation of ceramides in WT and CerS2 null BMCs, as well as upregulation of very long chain lactosylceramides. However, in CerS2 null BMCs, G-CSF failed to induce translocation of G-CSF-R into DRMs, leading to reduced phosphorylation of Lyn and reduced CXCR2 expression. Interestingly, G-CSF signaling in CerS6 null BMCs was not affected. In conclusion, very long chain ceramides are important for G-CSF signaling and translocation of G-CSF-R into DRMs.
Identifiants
pubmed: 30679689
doi: 10.1038/s41598-018-37342-8
pii: 10.1038/s41598-018-37342-8
pmc: PMC6345911
doi:
Substances chimiques
Detergents
0
Lactosylceramides
0
Receptors, Granulocyte Colony-Stimulating Factor
0
STAT3 Transcription Factor
0
Granulocyte Colony-Stimulating Factor
143011-72-7
CERS6 protein, mouse
EC 2.3.1.24
Cers2 protein, mouse
EC 2.3.1.24
Sphingosine N-Acyltransferase
EC 2.3.1.24
lyn protein-tyrosine kinase
EC 2.7.10.2
src-Family Kinases
EC 2.7.10.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
747Références
J Biol Chem. 1999 Jul 16;274(29):20313-7
pubmed: 10400653
Mol Membr Biol. 1999 Apr-Jun;16(2):145-56
pubmed: 10417979
Biochem J. 1999 Dec 15;344 Pt 3:895-901
pubmed: 10585879
Immunity. 2001 Feb;14(2):193-204
pubmed: 11239451
Stem Cells. 2001;19(5):378-87
pubmed: 11553846
FEBS Lett. 2001 Oct 26;507(2):163-8
pubmed: 11684091
Blood. 2002 Feb 1;99(3):879-87
pubmed: 11806990
Bioinformatics. 2002 Feb;18(2):333-4
pubmed: 11847087
Nucleic Acids Res. 2003 Jul 1;31(13):3651-3
pubmed: 12824386
Genome Biol. 2003;4(11):234
pubmed: 14611651
J Biol Chem. 2004 Feb 20;279(8):6905-10
pubmed: 14699146
Immunity. 2004 Feb;20(2):153-65
pubmed: 14975238
Biochem J. 2005 Aug 15;390(Pt 1):263-71
pubmed: 15823095
Hum Mol Genet. 2005 Oct 1;14(19):2881-92
pubmed: 16115811
Nat Med. 2005 Oct;11(10):1056-8
pubmed: 16170323
Biochem J. 2006 Sep 15;398(3):531-8
pubmed: 16753040
Ann Neurol. 2006 Jul;60(1):12-21
pubmed: 16802293
J Biol Chem. 2008 Feb 29;283(9):5677-84
pubmed: 18165233
Cytokine. 2008 Jun;42(3):277-88
pubmed: 18400509
Exp Neurol. 2009 Nov;220(1):44-56
pubmed: 19616545
J Biol Chem. 2010 Apr 2;285(14):10902-10
pubmed: 20110363
J Biol Chem. 2010 Apr 2;285(14):10911-23
pubmed: 20110366
Blood. 2010 Apr 22;115(16):3354-63
pubmed: 20185584
Expert Rev Proteomics. 2011 Apr;8(2):263-77
pubmed: 21501018
J Pharmacol Pharmacother. 2011 Jan;2(1):49-51
pubmed: 21701650
J Cell Biochem. 2012 Jan;113(1):329-39
pubmed: 21928351
Hepatology. 2013 Feb;57(2):525-32
pubmed: 22911490
Nat Rev Immunol. 2013 Mar;13(3):159-75
pubmed: 23435331
Nat Struct Mol Biol. 2013 Apr;20(4):469-76
pubmed: 23454976
J Innate Immun. 2013;5(4):304-14
pubmed: 23571274
J Biol Chem. 2013 Oct 25;288(43):30904-16
pubmed: 24019516
Cell Death Dis. 2013 Nov 21;4:e929
pubmed: 24263103
Langmuir. 2014 Mar 4;30(8):2117-28
pubmed: 24490728
Biochim Biophys Acta. 2014 Dec;1841(12):1754-66
pubmed: 25241943
J Exp Med. 2015 Jan 12;212(1):23-35
pubmed: 25559893
Brain Behav Immun. 2015 May;46:280-92
pubmed: 25697397
Immunol Cell Biol. 2015 Oct;93(9):825-36
pubmed: 25833068
J Vis Exp. 2016 May 08;(111):
pubmed: 27214391
Cell Mol Life Sci. 2017 Aug;74(16):3039-3055
pubmed: 28405720
Blood. 1994 Sep 15;84(6):1760-4
pubmed: 7521688
J Biol Chem. 1998 Feb 6;273(6):3230-5
pubmed: 9452436
Blood. 1999 Jan 1;93(1):341-9
pubmed: 9864179